|
1
|
Seto WK, Lo YR, Pawlotsky JM and Yuen MF:
Chronic hepatitis B virus infection. Lancet. 392:2313–2324.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yuen MF, Chen DS, Dusheiko GM, Janssen
HLA, Lau DTY, Locarnini SA, Peters MG and Lai CL: Hepatitis B virus
infection. Nat Rev Dis Primers. 4(18035)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Maini MK and Pallett LJ: Defective T-cell
immunity in hepatitis B virus infection: Why therapeutic
vaccination needs a helping hand. Lancet Gastroenterol Hepatol.
3:192–202. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Park JJ, Wong DK, Wahed AS, Lee WM, Feld
JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, et al:
Hepatitis B virus--specific and global T-cell dysfunction in
chronic hepatitis B. Gastroenterology. 150:684–695.e5.
2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bertoletti A and Naoumov NV: Translation
of immunological knowledge into better treatments of chronic
hepatitis B. J Hepatol. 39:115–124. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bertoletti A and Ferrari C: Innate and
adaptive immune responses in chronic hepatitis B virus infections:
Towards restoration of immune control of viral infection. Gut.
61:1754–1764. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bertoletti A and Ferrari C: Kinetics of
the immune response during HBV and HCV infection. Hepatology.
38:4–13. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chang C, Enders G, Sprengel R, Peters N,
Varmus HE and Ganem D: Expression of the precore region of an avian
hepatitis B virus is not required for viral replication. J Virol.
61:3322–3325. 1987.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen HS, Kew MC, Hornbuckle WE, Tennant
BC, Cote PJ, Gerin JL, Purcell RH and Miller RH: The precore gene
of the woodchuck hepatitis virus genome is not essential for viral
replication in the natural host. J Virol. 66:5682–5684.
1992.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Schlicht HJ, Salfeld J and Schaller H: The
duck hepatitis B virus pre-C region encodes a signal sequence which
is essential for synthesis and secretion of processed core proteins
but not for virus formation. J Virol. 61:3701–3709. 1987.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Boni C, Laccabue D, Lampertico P, Giuberti
T, Viganò M, Schivazappa S, Alfieri A, Pesci M, Gaeta GB, et al:
Restored function of HBV-specific T cells after long-term effective
therapy with nucleos(t)ide analogues. Gastroenterology.
143:963–973.e9. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen M, Sällberg M, Hughes J, Jones J,
Guidotti LG, Chisari FV, Billaud JN and Milich DR: Immune tolerance
split between hepatitis B virus precore and core proteins. J Virol.
79:3016–3027. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Milich D and Liang TJ: Exploring the
biological basis of hepatitis B e antigen in hepatitis B virus
infection. Hepatology. 38:1075–1086. 2003.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Manigold T and Racanelli V: T-cell
regulation by CD4 regulatory T cells during hepatitis B and C virus
infections: Facts and controversies. Lancet Infect Dis. 7:804–813.
2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Stoop JN, van der Molen RG, Baan CC, van
der Laan LJ, Kuipers EJ, Kusters JG and Janssen HL: Regulatory T
cells contribute to the impaired immune response in patients with
chronic hepatitis B virus infection. Hepatology. 41:771–778.
2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Aalaei-Andabili SH and Alavian SM:
Regulatory T cells are the most important determinant factor of
hepatitis B infection prognosis: A systematic review and
meta-analysis. Vaccine. 30:5595–5602. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lin CY, Tsai MC, Huang CT, Hsu CW, Tseng
SC, Tsai IF, Chen YC, Yeh CT, Sheen IS and Chien RN: Liver injury
is associated with enhanced regulatory T-cell activity in patients
with chronic hepatitis B. J Viral Hepat. 14:503–511.
2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Stoop JN, van der Molen RG, Kuipers EJ,
Kusters JG and Janssen HL: Inhibition of viral replication reduces
regulatory T cells and enhances the antiviral immune response in
chronic hepatitis B. Virology. 361:141–148. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
El-Badawy O, Sayed D, Badary MS,
Abd-Alrahman ME, El-Feky MA and Thabit AG: Relations of regulatory
T cells with hepatitis markers in chronic hepatitis B virus
infection. Hum Immunol. 73:335–341. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Peng G, Li S, Wu W, Sun Z, Chen Y and Chen
Z: Circulating CD4+ CD25+ regulatory T cells correlate with chronic
hepatitis B infection. Immunology. 123:57–65. 2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chen W, Jin W, Hardegen N, Lei KJ, Li L,
Marinos N, McGrady G and Wahl SM: Conversion of peripheral
CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta
induction of transcription factor Foxp3. J Exp Med. 198:1875–1886.
2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Peng Y, Laouar Y, Li MO, Green EA and
Flavell RA: TGF-beta regulates in vivo expansion of
Foxp3-expressing CD4+CD25+ regulatory T cells responsible for
protection against diabetes. Proc Natl Acad Sci USA. 101:4572–4577.
2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Maruyama T, Iino S, Koike K, Yasuda K and
Milich DR: Serology of acute exacerbation in chronic hepatitis B
virus infection. Gastroenterology. 105:1141–1151. 1993.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Masopust D, Sivula CP and Jameson SC: Of
mice, dirty mice, and men: Using mice To understand human
immunology. J Immunol. 199:383–388. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Turner MS, Kane LP and Morel PA: Dominant
role of antigen dose in CD4+Foxp3+ regulatory T cell induction and
expansion. J Immunol. 183:4895–4903. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shevach EM: From vanilla to 28 flavors:
Multiple varieties of T regulatory cells. Immunity. 25:195–201.
2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kang J, Huddleston SJ, Fraser JM and
Khoruts A: De novo induction of antigen-specific CD4+CD25+Foxp3+
regulatory T cells in vivo following systemic antigen
administration accompanied by blockade of mTOR. J Leukoc Biol.
83:1230–1239. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gottschalk RA, Corse E and Allison JP: TCR
ligand density and affinity determine peripheral induction of Foxp3
in vivo. J Exp Med. 207:1701–1711. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li MO and Rudensky AY: T cell receptor
signalling in the control of regulatory T cell differentiation and
function. Nat Rev Immunol. 16:220–233. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Moon JJ, Chu HH, Pepper M, McSorley SJ,
Jameson SC, Kedl RM and Jenkins MK: Naive CD4(+) T cell frequency
varies for different epitopes and predicts repertoire diversity and
response magnitude. Immunity. 27:203–213. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Josefowicz SZ, Lu LF and Rudensky AY:
Regulatory T cells: Mechanisms of differentiation and function.
Annu Rev Immunol. 30:531–564. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Khorramdelazad H, Hassanshahi G, Nasiri
Ahmadabadi B and Kazemi Arababadi M: High serum levels of TGF-β in
Iranians with chronic HBV infection. Hepat Mon.
12(e7581)2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li H, Zhai N, Wang Z, Song H, Yang Y, Cui
A, Li T, Wang G, Niu J, Crispe IN, et al: Regulatory NK cells
mediated between immunosuppressive monocytes and dysfunctional T
cells in chronic HBV infection. Gut. 67:2035–2044. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tsai KN, Kuo CF and Ou JJ: Mechanisms of
hepatitis B virus persistence. Trends Microbiol. 26:33–42.
2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yang F, Yu X, Zhou C, Mao R, Zhu M, Zhu H,
Ma Z, Mitra B, Zhao G, et al: Hepatitis B e antigen induces the
expansion of monocytic myeloid-derived suppressor cells to dampen
T-cell function in chronic hepatitis B virus infection. PLoS
Pathog. 15(e1007690)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ciupe SM: Modeling the dynamics of
hepatitis B infection, immunity, and drug therapy. Immunol Rev.
285:38–54. 2018.PubMed/NCBI View Article : Google Scholar
|
